Literature DB >> 19217096

Cellular senescence in usual type uterine leiomyoma.

Jordan Laser1, Peng Lee, Jian-Jun Wei.   

Abstract

OBJECTIVE: To evaluate the role of senescence in symptomatic patients with multifibroids.
DESIGN: A cohort study.
SETTING: University research laboratory. PATIENT(S): Eighty-six fibroids collected from 14 patients who underwent myomectomy or hysterectomy. INTERVENTION(S): Senescence-associated beta-galactosidase (SA-beta-Gal) stain in fresh-frozen tissue; reverse-transcription polymerase chain reaction (RT-PCR); MicroRNA in situ hybridization (MISH); immunohistochemistry in formalin-fixed paraffin-embedded tissue. MAIN OUTCOME MEASURE(S): Senescence measured by percentage of SA-beta-Gal-positive cells; levels of let-7 microRNAs measured by RT-PCR and MISH; expression of p16(INK4a), Ki-67, HMGA1, and HMGA2 scaled by immunoreactivity. RESULT(S): About 58% (48 of 82) of tumors showed significant senescent change (SA-beta-Gal positive) in >10% of the tumor volume. The overall trend was a higher level of senescence in small fibroids and older-aged women. Senescent fibroids were additionally shown to have, high levels of let-7 c, d, and f-2 and a low Ki-67 index. CONCLUSION(S): Senescence is a common cellular change in a large proportion of usual type fibroids. Similarly, senescence may explain the variation in growth rates of these tumors, and may prove to be an important molecular and cellular target in prevention of fibroid growth. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217096     DOI: 10.1016/j.fertnstert.2008.12.116

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

1.  Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.

Authors:  Jia Xie; Julianne Ubango; Yanli Ban; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei
Journal:  Genes Chromosomes Cancer       Date:  2018-08-20       Impact factor: 5.006

2.  Cellular senescence in usual type uterine leiomyoma.

Authors:  Jian-Jun Wei; Jordan Laser; Peng Lee
Journal:  Fertil Steril       Date:  2010-11       Impact factor: 7.329

3.  Inference of Target Gene Regulation via miRNAs during Cell Senescence by Using the MiRaGE Server.

Authors:  Y-H Taguchi
Journal:  Aging Dis       Date:  2012-06-07       Impact factor: 6.745

4.  Reply of the Authors: Cellular senescence in usual type uterine leiomyoma.

Authors:  Jian-Jun Wei
Journal:  Fertil Steril       Date:  2010-07       Impact factor: 7.329

5.  Cellular senescence in usual type uterine leiomyoma.

Authors:  Donna D Baird; Barbara Davis; Shyamal D Peddada
Journal:  Fertil Steril       Date:  2010-06-03       Impact factor: 7.329

6.  Inactivation of AKT induces cellular senescence in uterine leiomyoma.

Authors:  Xiaofei Xu; Zhenxiao Lu; Wenan Qiang; Vania Vidimar; Beihua Kong; J Julie Kim; Jian-Jun Wei
Journal:  Endocrinology       Date:  2014-01-29       Impact factor: 4.736

Review 7.  MicroRNAs: new players in cataract.

Authors:  Xin Yu; Heyi Zheng; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

8.  Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence.

Authors:  Joseph M Dhahbi; Hani Atamna; Dario Boffelli; Wendy Magis; Stephen R Spindler; David I K Martin
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

9.  Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium.

Authors:  Dominique N Markowski; Burkhard M Helmke; Arlo Radtke; Jennifer Froeb; Gazanfer Belge; Sabine Bartnitzke; Werner Wosniok; Iris Czybulka-Jachertz; Ulrich Deichert; Jörn Bullerdiek
Journal:  BMC Womens Health       Date:  2012-01-10       Impact factor: 2.809

Review 10.  Effect of aging on the female reproductive function.

Authors:  Koumei Shirasuna; Hisataka Iwata
Journal:  Contracept Reprod Med       Date:  2017-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.